Antibody–Drug Conjugate to Treat Meningiomas is a research paper published in Pharmaceuticals (2021). On theSindex it has a DataRank of 0. It has been cited 13 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01CA238273-01A1; 1R01CA242917-01A1; R01NS095626
National Institutes of Health
Grant: 1R01CA242917-01A1
Identifying a New Biological Target for Breast Cancer Therapy That Contributes to Disparities for African-American Women
National Institutes of Health
Grant: 1R01CA238273-01A1
Synergistic Targeted Therapy of Antibody-Drug Conjugates for Triple-Negative Breast Cancer
National Institutes of Health
Grant: 5R01NS095626-03
Targeting PRMT5 in Cancer Initiating Cells as a New Therapy for Glioblastoma
Fields of Study
Keywords
Sustainable Development Goals